| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/29/2013 | CA2658190C Di-amino-substituted heterocyclic compounds and methods of use |
| 01/29/2013 | CA2570673C Compounds and methods for treating dyslipidemia |
| 01/29/2013 | CA2544492C Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 01/29/2013 | CA2537345C Intermediates for the preparation of oxazolidinone-quinolone hybrids |
| 01/24/2013 | WO2013012848A1 Benzamides |
| 01/24/2013 | WO2013012844A1 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| 01/24/2013 | WO2013012829A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2013012827A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2013011033A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | WO2013011010A1 Fungizide mixtures |
| 01/24/2013 | WO2013010839A1 Novel and selective ccr2 antagonists |
| 01/24/2013 | WO2012010663A9 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 01/24/2013 | US20130023660 Carboxamide Compounds and Methods for Using the Same |
| 01/24/2013 | US20130023566 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives |
| 01/24/2013 | US20130023563 Amidinoaniline derivative |
| 01/24/2013 | US20130023539 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of g-protein coupled receptor 43 (gpr43) |
| 01/24/2013 | US20130023534 Pyrazolyl-pyrimidines as kinase inhibitors |
| 01/24/2013 | US20130023533 New 5-alkynyl-pyridines |
| 01/24/2013 | US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023525 Gyrase inhibitors and uses thereof |
| 01/24/2013 | US20130023522 Benzamides |
| 01/24/2013 | US20130023519 5-alkynyl-pyridines |
| 01/24/2013 | US20130023518 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130023495 Uses of dgat1 inhibitors |
| 01/24/2013 | US20130023494 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 01/24/2013 | CA2842352A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | CA2834199A1 Benzamides |
| 01/23/2013 | EP2548873A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 01/23/2013 | EP2548871A1 Cycloalkyl-substituted imidazole derivative |
| 01/23/2013 | EP2548865A1 Novel bis-indolic derivatives, their uses in particular as antibacterials |
| 01/23/2013 | EP2548618A2 Organic compounds |
| 01/23/2013 | EP2547664A1 Morpholinylquinazolines |
| 01/23/2013 | EP2547656A1 Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | EP2547655A2 Arylsulfonamide ccr3 antagonists |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892766A Kinase inhibitors and method of treating cancer with same |
| 01/23/2013 | CN102892761A 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 01/23/2013 | CN102892758A Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | CN102892754A Arylsulfonamide ccr3 antagonists |
| 01/23/2013 | CN102887891A N4-phenyl-quinaz0line-4 -amine derivatives and related compounds |
| 01/23/2013 | CN101809006B Method of producing benzoxazinone-based compound |
| 01/23/2013 | CN101595105B 2-substituted 5-membered heterocycles as SCD inhibitors |
| 01/22/2013 | US8357706 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 01/22/2013 | US8357703 Pyridines |
| 01/22/2013 | US8357685 Substituted diketopiperazines and their use as oxytocin antagonists |
| 01/22/2013 | US8357684 Thyazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase |
| 01/22/2013 | US8357683 Compounds for enzyme inhibition |
| 01/22/2013 | US8357682 Gamma secretase modulators |
| 01/22/2013 | CA2672271C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 01/22/2013 | CA2650932C Substituted spirocyclic cgrp receptor antagonists |
| 01/22/2013 | CA2537812C C-met modulators and method of use |
| 01/17/2013 | WO2013009259A1 Novel compounds and their use in therapy |
| 01/17/2013 | WO2013008162A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
| 01/17/2013 | WO2013007676A1 Aminomethyl quinolone compounds |
| 01/17/2013 | WO2013007663A1 2-benzylsulfanyl[1,3,4]-oxadiazole derivatives, and medical use thereof |
| 01/17/2013 | WO2013007387A1 Novel fxr (nr1h4) binding and activity modulating compounds |
| 01/17/2013 | WO2012157980A3 Manufacturing method of azilsartan |
| 01/17/2013 | WO2012157977A3 Manufacturing method of heterocyclic compound |
| 01/17/2013 | WO2012129452A3 Propynoic acid carbamoyl methyl-amides and pharmaceutical compositions and methods based thereon |
| 01/17/2013 | US20130018075 Heterocyclic inhibitors of mek and methods of use thereof |
| 01/17/2013 | US20130018074 New compounds |
| 01/17/2013 | US20130018066 Heterocyclic aspartyl protease inhibitors |
| 01/17/2013 | US20130018058 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 01/17/2013 | US20130018055 New aryl-benzocycloalkyl amide derivatives |
| 01/17/2013 | US20130018054 New compounds |
| 01/17/2013 | US20130018048 Oxazole derivatives useful as modulators of faah |
| 01/17/2013 | US20130018046 Acetylenic Heteroaryl Compounds |
| 01/17/2013 | US20130018044 New inhibitors of cyclophilins and uses thereof |
| 01/17/2013 | US20130018043 Aminomethyl quinolone compounds |
| 01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
| 01/17/2013 | US20130018033 Raf inhibitor compounds and methods of use thereof |
| 01/17/2013 | US20130018030 New compounds, pharmaceutical compositions and uses thereof |
| 01/17/2013 | US20130017196 Substituted imidazole derivatives |
| 01/17/2013 | US20130017194 Fak inhibitors |
| 01/17/2013 | CA2841113A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
| 01/17/2013 | CA2839395A1 Aminomethyl quinolone compounds |
| 01/17/2013 | CA2839357A1 Novel fxr (nr1h4) binding and activity modulating compounds |
| 01/16/2013 | EP2546253A1 Substituted dihydropyrazolones for the treatment of cardiovascular and hematological diseases |
| 01/16/2013 | EP2546252A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them |
| 01/16/2013 | EP2546251A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them |
| 01/16/2013 | EP2546250A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them |
| 01/16/2013 | EP2546249A1 5-Alkynyl-pyridines |
| 01/16/2013 | EP2546246A2 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/16/2013 | EP2546240A1 Benzoylpyrazole compounds and herbicides containing them |
| 01/16/2013 | EP2546232A1 Diphenyl Substituted Alkanes |
| 01/16/2013 | EP2545964A1 Novel FXR (NR1H4) binding and activity modulating compounds |
| 01/16/2013 | EP2545048A1 Raltegravir salts and crystalline forms thereof |
| 01/16/2013 | EP2545042A1 Compounds for the treatment of hepatitis c |
| 01/16/2013 | EP2281822B1 New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/16/2013 | CN102884204A Sequence-selective recognition of nucleic acids using nanoparticle probes |
| 01/16/2013 | CN102884156A Light-emitting device material and light-emitting device |
| 01/16/2013 | CN102884060A Heterocyclic compounds useful for kinase inhibition |
| 01/16/2013 | CN102884052A Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/16/2013 | CN102884044A Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/16/2013 | CN102875542A Oxadiazole group-containing red-light emitting iridium complex, and preparation method and use thereof |